# Assessment of the Link Between Monomeric Functional Form Plasma Level of Vasostatin-1 and Occurrence of New Onset Atrial Fibrillation in Severe Intensive Care Patients

> **NCT03457155** · NA · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 150 (estimated)

## Conditions studied

- Atrial Fibrillation
- Shock

## Interventions

- **OTHER:** VS-I dosing in plasma samples

## Key facts

- **NCT ID:** NCT03457155
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-18
- **Primary completion:** 2023-07
- **Final completion:** 2023-07
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03457155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03457155, "Assessment of the Link Between Monomeric Functional Form Plasma Level of Vasostatin-1 and Occurrence of New Onset Atrial Fibrillation in Severe Intensive Care Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03457155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*